OurCrowd, the largest investment crowdfunding platform in the world, has announced the launch of the OurCrowd Medtech Fund joining their existing portfolio of 18 funds. The $50 million fund will focus exclusively on investing in disruptive medical technology – a fast-growing sector of healthcare. This is OurCrowd’s first fund solely dedicated to the Medtech market which is estimated to be valued globally at $433.7 billion.
The Medtech fund will be led by managing partners Dr. Morris Laster and Dr. Morry Blumenfeld.
Dr. Blumenfeld is a prominent authority on the development and commercialization of healthcare technology. He was among the managers responsible for the development of GE’s computed tomography and magnetic resonance imaging product line.
Dr. Laster is a healthcare executive and entrepreneur with over 25 years of experience in the biopharmaceutical industry and was responsible for six IPO’s on NASDAQ, AIM, and TASE.
Current notable OurCrowd Medtech investments include:
- AlphaTau Medical: new radiotherapy for solid cancer tumors.
- UPnRIDE : electric wheelchair that enables stable standing and mobility for handicapped individuals
- Insightec: MR-guided focused ultrasound for non-invasive surgery
- MeMed: preventing misuse of antibiotics
- Zebra Medical Vision: Medical imaging insights platform with algorithm-based assistance for radiologists
- Sight Diagnostics: Point of care blood diagnostics utilizing computer vision
- Memic: Robotic arm that extends & improves upon surgeon’s natural movements
- Syqe Medical – World’s first selective-dose pharmaceutical grade medicinal plants inhaler
Jon Medved, founder and CEO or OurCrowd, said the creation of their Medtech Fund is a natural extension of the investments they have been making:
“This move will give investors even more accessibility to promising Israeli startups upending the way we live and saving lives.”
Since 2013, OurCrowd reports that they have identified, scaled and financed more than $78 million in over 20 medical technologies.
Dr. Blumenfeld said that trends in worldwide population demographics are driving rapid growth in the healthcare sector, resulting in a substantial need for medical innovation:
“As the ‘Start-Up Nation,’ Israel offers the perfect backdrop to source and develop early stage medical technology companies with global impact potential.”
Dr. Laster added that the rising cost of healthcare and an increased focus on outcomes and value means it is time to challenge the status quo of healthcare delivery:
“The only way to innovate in today’s healthcare environment is to support the companies that are bold enough to truly change the way healthcare is delivered.”
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!